4-163129120-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_138386.3(NAF1):c.1262A>G(p.Gln421Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138386.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAF1 | ENST00000274054.3 | c.1262A>G | p.Gln421Arg | missense_variant | 8/8 | 1 | NM_138386.3 | ENSP00000274054.2 | ||
NAF1 | ENST00000422287.6 | c.1034-2005A>G | intron_variant | 1 | ENSP00000408963.2 | |||||
NAF1 | ENST00000509434.5 | c.114+8079A>G | intron_variant | 3 | ENSP00000427518.1 | |||||
NAF1 | ENST00000509884.1 | n.718A>G | splice_region_variant, non_coding_transcript_exon_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151988Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 249984Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135338
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461260Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 726970
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151988Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74236
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 21, 2023 | This variant has not been reported in the literature in individuals affected with NAF1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant is present in population databases (no rsID available, gnomAD 0.008%). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 421 of the NAF1 protein (p.Gln421Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at